Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial von Malekzadeh, Reza, Abedini, Atefeh, Mohsenpour, Behzad, Sharifipour, Ehsan, Ghasemian, Roya, Javad-Mousavi, Seyed Ali, Khodashahi, Rozita, Darban, Mahboobeh, Kalantari, Saeed, Abdollahi, Nafiseh, Salehi, Mohammad Reza, Rezaei Hosseinabadi, Abbas, Khorvash, Farzin, Valizadeh, Melika, Dastan, Farzaneh, Yousefian, Sahar, Hosseini, Hamed, Anjidani, Nassim, Tabarsi, Payam

Volltext